Wolverine Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Wolverine Trading’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-62,300	Closed	-$212K	–	5876
2018 Q3	$212K	Sell	62,300 -32,100	-34%	-$116K	﹤0.01%	4196
2018 Q2	$386K	Hold	94,400	–	–	﹤0.01%	3419
2018 Q1	$386K	Sell	94,400 -56,300	-37%	-$262K	﹤0.01%	3419
2017 Q4	$701K	Buy	150,700 +114,900	+321%	+$633K	﹤0.01%	2613
2017 Q3	$254K	Sell	35,800 -28,300	-44%	-$203K	﹤0.01%	3501
2017 Q2	$451K	Sell	64,100 -10,400	-14%	-$65K	﹤0.01%	2545
2017 Q1	$454K	Buy	+74,500	New	+$408K	﹤0.01%	2508
2016 Q4	–	Sell	-84,800	Closed	-$437K	–	5572
2016 Q3	$437K	Sell	84,800 -60,800	-42%	-$328K	﹤0.01%	2743
2016 Q2	$984K	Buy	+145,600	New	+$814K	0.01%	1607

Wolverine Trading's KERX Position: Q4 2018 in Review

Wolverine Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 21,732 shares — an estimated $74K sold.

Wolverine Trading first reported a position in KERX in Q2 2016 and held it in 5 quarters. The position peaked at $865K in Q2 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Wolverine Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Wolverine Trading sold 21,732 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $74K.
Wolverine Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2016 and held it in 5 quarters.
Wolverine Trading's Keryx Biopharmaceuticals Inc position peaked at $865K in Q2 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Wolverine Trading's 13F filing for Q4 2018, filed 14 Feb 2019.